Staphylococci in Human Disease

Eds.: Crossley, Kent K., Jefferson, Kimberly K., Archer, Gordon I. et al.

• Gebundenes Buch

Produktbeschreibung

Staphylococci remain the most important cause of hospital-acquiredinfections in the U.S. and MRSA has become the most common cause ofskin and soft tissue infection in many parts of the world.
There is now a much greater understanding of the physiology andevolution of the staphylococci and this new edition reflects therapid advancements in knowledge about this pathogen and provides acomprehensive review from both clinical and basic scienceperspectives.

The first section addresses the basic biology of thestaphylococci, their molecular genetics, host defenses and hostevasion, virulence determinants, mechanisms of antibioticresistance, and laboratory techniques. The second section dealswith epidemiology, and the third section provides an overview ofthe varied clinical manifestations of human staphylococcalinfections. The fourth section covers prevention and treatment ofthese often life-threatening infections.

Written by experts from around the globe, this book is essentialreading for all clinicians and basic scientists studying thestaphylococci.

Produktdetails

• Verlag: Wiley & Sons / Wiley-Blackwell
• Artikelnr. des Verlages: 1A405163320
• 2. Aufl.
• Seitenzahl: 640
• Erscheinungstermin: 1. November 2009
• Englisch
• Abmessung: 284mm x 231mm x 35mm
• Gewicht: 2010g
• ISBN-13: 9781405163323
• ISBN-10: 1405163321
• Artikelnr.: 27009629

Autorenporträt

Kent B. Crossley MD University of Minnesota Medical School, MN, USA Kimberly K. Jefferson PhD Virginia Commonwealth University School of Medicine, VA, USA Gordon L. Archer MD Virginia Commonwealth University School of Medicine, VA, USA Vance G. Fowler Jr. MD, MHS Duke University Medical Center, NC, USA

Inhaltsangabe

Section I: The Organisms Biology and Taxonomy. 1 The biology of
staphylococci (Greg A. Somerville and Richard A. Proctor). 2 Genomics of
the Staphylococci. (Steven R. Gill). 3 The evolution and taxonomy of
staphylococci (Barry N. Kreiswirth, Barun Mathema, José R. Mediavilla and
Liang Chen). 4 The molecular basis of pathogenicity (Mark S. Smeltzer, Chia
Y. Lee, Nada Harik and Mark E. Hart). 5 Adaptation to stress: biofilms and
small colony variants (Karl M. Thompson and Kimberly K Jefferson). 6
Exotoxins (Patrick M. Schlievert, John K. McCormick, Gregory A. Bohach and
Douglas H. Ohlendorf). 7 Host Defense Against Staphylococcal Infection. 7a
The mechanism of host defense (Hattie D. Gresham). 7b Evasion of Host
Defenses (Timothy J. Foster). Antimicrobial Resistance in Staphylococci. 8
Resistance to beta-lactam antibiotics (Brigitte Berger-Bächi, Maria
Magdalena Senn, Miram Ender, Kati Seidl, Judith Hübscher, Bettina
Schulthess, Roni Heusser, Patricia Stutzmann Meier and Nadine McCallum). 9
Resistance to glycopeptides (Keiichi Hiramatsu). 10 Resistance to other
agents (David C. Hooper and Jacob Strahilevitz). Laboratory Studies. 11
Issues in the identification and susceptibility testing of staphylococci
(Betty A. Forbes). Section II: Epidemiology of Staphylococcal Infection. 12
Colonization with Staphylococcus aureus and the role of colonization in
causing infection (Henri A. Verbrugh). 13 Epidemiology of
community-associated Staphylococcus aureus infections (Rachel J. Gorwitz
and John A. Jernigan). 14 Epidemiology of Healthcare-Associated
Staphylococcus aureus Infections (Andrew E. Simor and Mark Loeb). 15
Epidemiology of Coagulase-Negative Staphylococci and Infections Caused by
these Organisms (Kathie L.Rogers, Paul D. Fey and Mark E. Rupp). Section
III: Diseases Caused by Staphylococci. 16 Staphylococcus Aureus Bacteremia
and Endocarditis (Zeina A. Kanafani, Sara E. Cosgrove and Vance G. Fowler
Jr). 17 Surgical Site Infections and Surgical Prophylaxis (Deverick J.
Anderson and Keith S. Kaye). 18 Infections of Intravascular Catheters and
Vascular Devices (Hidetaka Yanagi and Robert J. Sherertz). 19 Skin and soft
tissue infections (Martin E. Stryjewski, Esteban C. Nannini and G. Ralph.
Corey). 20 Central nervous system infections (Karen L. Roos). 21 Diseases
of the Eye (Linda A. Ficker). 22 Osteomyelitis and Other Bone and Joint
Infections (Odette C. El Helou, Elie F. Berbari, and Douglas R. Osmon). 23
Staphylococcal Pneumonia (Ethan Rubinstein and Marin H. Kollef). 24 Urinary
tract infections (S. Gatermann and Kent B. Crossley). 25 Toxic Shock
Syndrome (Aaron DeVries). 26 Toxin-mediated syndromes (Tristan Ferry and
Jerome Etienne). 27 Staphylococcal Diarrhea and Enterocolitis (Mark H.
Wilcox). 28 Infections in Immunocompromised Patients (Lisa E. Davidson and
Helen W. Boucher). 29 Clinical Manifestations of Community-Acquired MRSA
Infections (Brian S. Schwartz and Henry F. Chambers). Section IV:
Prevention and Treatment of Staphylococcal Infections. 30 Elimination of S.
aureus carriage: Importance and strategies (Loreen A. Herwaldt and John M.
Boyce). 31 Treatment of Staphylococcal Infections (Kent B. Crossley and
Joseph John). 32 Vaccine-based strategies for prevention of Staphylococcus
aureus infection (Adam C. Schaffer and Jean C. Lee). Index.